The analysis of the K-M survival curve (Figure 7) revealed that patients with glioblastoma multiforme who had low PER3 expression levels had significantly lower overall survival, disease-specific survival, and progression-free interval compared to those with high levels of PER3 expression. This evidence concerns the gene PER3 and glioblastoma.